Orexigen Therapeutics’ (OREX) CEO Mike Narachi on Q1 2014 Results – Earnings Call Transcript
[at Seeking Alpha] – Mike Narachi Thank you, Heather. And thank you for joining us today. The NB32 PDUFA date is now a short 4.5 weeks away and I hope we successfully convey to you today our excitement for the events in 2014. … more
View todays social media effects on OREX
View the latest stocks trending across Twitter. Click to view dashboard